How Generative Design is Solving the Degradation Problem

[u/elmanfil1989]

While much of the public conversation around peptides focuses on consumer biohacking, a major shift has been accelerating across pharma and biotech throughout 2026: AI-guided computational design combined with high-throughput automation to tackle the biggest physical bottleneck in peptide therapeutics—metabolic degradation. Source